Iconic Labs PLC Issue of Equity in respect of Warrants (2677B)
October 06 2020 - 8:13AM
UK Regulatory
TIDMICON
RNS Number : 2677B
Iconic Labs PLC
06 October 2020
Iconic Labs Plc ("Iconic Labs" or the "Company")
Issue of Equity in respect of Warrants
Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional
new media and technology business, announces that, following the
issuance of the Prospectus on 26 March 2020, and pursuant to the
Deed of Issuance and Subscription dated 5 August 2019 in respect of
which non-convertible notes (the "Notes") together with share
subscription warrants (the "Warrants"), which were automatically
attached to the Notes, were issued by the Company to European High
Growth Opportunities Securitization Fund (the "Investor"), and for
which the Company has received a notice of exercise of the
principal amount of GBP410,000 of Warrants from the Investor
resulting in the issue to the Investor of 4,555,555,555 new
ordinary shares in the Company ("Warrant Shares"). Shareholders
should note that due to the concurrent redemption of the equivalent
amount of Notes having an effect similar to set-off, no net cash
proceeds have been received by the Company as a result of the
exercise of the Warrants, but the aggregate amount due to the
Investor has been reduced.
The Company has agreed, subject only to Admission (as defined
below), to issue the Warrant Shares and application will be made
for the Warrant Shares to be listed on the standard segment of the
Official List and to trading on the Main Market for listed
securities of the London Stock Exchange plc ("Admission").
It is expected that Admission will become effective and dealings
in the Warrant Shares will commence on or around 14th October 2020.
The Warrant Shares will rank pari passu in all respects with the
existing Ordinary Shares in the Company.
Following Admission of the Warrant Shares, the Company's
enlarged issued share capital will comprise 27,073,637,837 Ordinary
Shares with voting rights. The Company does not hold any shares in
treasury. The figure of 27,073,637,837 Ordinary Shares may be used
by shareholders in the Company as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
share capital of the Company under the Disclosure Guidance and
Transparency Rules of the Financial Conduct Authority.
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by
the Company to constitute inside information for the purposes of
the Market Abuse Regulation (EU) No. 596/2014. Upon the publication
of this announcement via a Regulatory Information Service, this
inside information is now considered to be in the public
domain.
**ENDS**
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by
the Company to constitute inside information for the purposes of
the Market Abuse Regulation (EU) No. 596/2014. Upon the publication
of this announcement via a Regulatory Information Service, this
inside information is now considered to be in the public
domain.
**ENDS**
For further information, please visit the Company's website
www.iconiclabs.co.uk or contact:
Damon Heath Shard Capital Partners Tel: +44 (0) 20 7186 9950
LLP
Iconic Labs ir@iconiclabs.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEFLFLFIILRIII
(END) Dow Jones Newswires
October 06, 2020 08:13 ET (12:13 GMT)
Widecells (LSE:WDC)
Historical Stock Chart
From Apr 2024 to May 2024
Widecells (LSE:WDC)
Historical Stock Chart
From May 2023 to May 2024